HIV may be suppressed by antiretroviral therapy, but its genetic material remains in the body. New research by scientists at the Leibniz Institute of Virology (LIV) in Hamburg suggests that some of
Migration has increased the genetic diversity of TB bacteria in Hamburg. Local transmission, however, has continued to be driven mainly by established strains. These findings are revealed in a long
Treatment with broad-spectrum antibiotics often leads to side effects, as it affects not only the pathogens but also the “good” bacteria in the gut. A research team from Hannover Medical School (MHH)
The ongoing Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the Congo is the second-largest Ebolavirus outbreak globally, with more than 6,000 confirmed cases and a mortality rate
The Incubator for Antimicrobial Therapies in Europe, INCATE, aims to support innovators in the early stages of developing therapies in the field of antimicrobial resistance. The German Center for
Why do the gut microbiomes of people from industrialized and non-industrialized regions differ? A study by the research team led by DZIF scientist Prof. Till Strowig of the Helmholtz Centre for
In acute, life-threatening infections, rapidly characterizing the microorganisms in a patient sample can help guide diagnosis and treatment. This is possible by using computational methods known as
According to the World Health Organization (WHO), tuberculosis (TB) affects more than 10 million people and causes over a million deaths each year, making it one of the world’s deadliest infectious
An international working group led by the German Society for Infectious Diseases (DGI) has developed a guideline for personalized phage therapy. Twenty professional organizations, 18 international
The current outbreak of Bundibugyo virus (BDBV) in the Democratic Republic of the Congo highlights the challenges of responding to rare but potentially devastating infectious diseases. Two studies led
